CD80 and neoplasm: IL6 also drives tumor microenvironment immunosuppression through multiple mechanisms, including reduced expression of MHC-II, CD80/86, and IL-12 in dendritic cells, differentiation of dendritic cells to immunosuppressive M2 macrophages [13], and suppression of T-cell-mediated anti-tumor immunity [14].